Providing Financial Incentives to Improve Adherence to Referral Eye Care Visits

Part of paid clinical trials in Birmingham, Alabama.

Sponsor
University of Alabama at Birmingham
Study ID
NCT04328207
Status
Completed

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Accepted

Interventions

  • No Financial Incentive — OTHER
    Standard of care eye health education
  • Financial Incentive — BEHAVIORAL
    Patients who are referred for an in-person follow-up exam will receive a financial incentive once the referral visit is completed.

Study Details

Glaucoma is a blinding eye disease increasingly common in older adults, particularly in African Americans, and often diagnosed late in the disease course. It is essential to develop novel health care models, utilizing telemedicine, to improve the ability to detect glaucoma at an earlier stage, and to provide a platform to manage this disease in community-based clinics so that further vision loss is prevented. Our goal is to improve the quality and accessibility of glaucoma detection and management among a vulnerable and at-risk segment of our population.

Key Dates

Start date
Nov 18, 2020
Status verified
Jul 2025
Primary completion
Jul 1, 2024
Completion
Jul 1, 2024

Study Design

Enrollment
900 participants (actual)
Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SCREENING

Arms

  • Other: No financial incentive
    This group will receive standard of care eye health education alone and no financial incentive for completing a referral visit.
  • Experimental: Financial incentive
    This group will receive a financial incentive once the referral visit is completed (if one was required) as well as eye health education.

Primary Outcome Measure

Percentage of Participants That Adhere to Referral Appointment [ Time Frame: The time frame will be whether they attended the referral appointment between the screening date until 6 months after the screening date. ]

Locations (1)

FacilityCityStateZIPSite coordinators
University of Alabama at BirminghamBirminghamAlabama35233-

Find similar trials in Birmingham, AL

Related Studies